371 related articles for article (PubMed ID: 22113154)
1. When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.
Manu P; Sarpal D; Muir O; Kane JM; Correll CU
Schizophr Res; 2012 Feb; 134(2-3):180-6. PubMed ID: 22113154
[TBL] [Abstract][Full Text] [Related]
2. Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases.
Manu P; Lapitskaya Y; Shaikh A; Nielsen J
Am J Ther; 2018; 25(2):e218-e223. PubMed ID: 29505490
[TBL] [Abstract][Full Text] [Related]
3. Clozapine Rechallenge Following Neuroleptic Malignant Syndrome: A Systematic Review.
Lally J; McCaffrey C; OʼMurchu C; Krivoy A; Guerandel A; MacCabe JH; Gaughran F
J Clin Psychopharmacol; 2019; 39(4):372-379. PubMed ID: 31205196
[TBL] [Abstract][Full Text] [Related]
4. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
Simon L; Cazard F
Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
[TBL] [Abstract][Full Text] [Related]
5. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
[TBL] [Abstract][Full Text] [Related]
6. Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review.
Verdoux H; Quiles C; de Leon J
Schizophr Res; 2019 Sep; 211():1-9. PubMed ID: 31378552
[TBL] [Abstract][Full Text] [Related]
7. Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review.
Corbeil O; Béchard L; Fournier É; Plante M; Thivierge MA; Lafrenière CÉ; Huot-Lavoie M; Brodeur S; Essiambre AM; Roy MA; Demers MF
J Psychopharmacol; 2023 Apr; 37(4):370-377. PubMed ID: 36794520
[TBL] [Abstract][Full Text] [Related]
8. Clozapine-Associated Myocarditis: A Protocol for Monitoring Upon Clozapine Initiation and Recommendations for How to Conduct a Clozapine Rechallenge.
Griffin JM; Woznica E; Gilotra NA; Nucifora FC
J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):180-185. PubMed ID: 33587399
[TBL] [Abstract][Full Text] [Related]
9. Rapid Rechallenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistant Schizophrenia Patient.
Ittasakul P; Archer A; Kezman J; Atsariyasing W; Goldman MB
Clin Schizophr Relat Psychoses; 2016; 10(2):120-2. PubMed ID: 27440213
[TBL] [Abstract][Full Text] [Related]
10. Successful rechallenge after clozapine-associated myocarditis.
Holden J; Begum M
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35550318
[TBL] [Abstract][Full Text] [Related]
11. Successful clozapine rechallenge in a patient with suspected drug induced lupus.
Pathak S; Cherry S; Samad S; Aftab A
BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30948402
[TBL] [Abstract][Full Text] [Related]
12. Rechallenging clozapine after neuroleptic malignant syndrome.
Anbalagan E; Ithman M; Lauriello J
Psychiatr Q; 2014 Sep; 85(3):345-8. PubMed ID: 24633526
[TBL] [Abstract][Full Text] [Related]
13. The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.
Lally J; Malik S; Krivoy A; Whiskey E; Taylor DM; Gaughran FP; Flanagan RJ; Mijovic A; MacCabe JH
J Clin Psychopharmacol; 2017 Oct; 37(5):600-604. PubMed ID: 28817489
[TBL] [Abstract][Full Text] [Related]
14. Protocol for Clozapine Rechallenge in a Case of Clozapine-Induced Myocarditis.
Shivakumar G; Thomas N; Sollychin M; Takács A; Kolamunna S; Melgar P; Connally F; Neil C; Bousman C; Jayaram M; Pantelis C
Can J Psychiatry; 2020 Jul; 65(7):448-453. PubMed ID: 31818135
[TBL] [Abstract][Full Text] [Related]
15. Clozapine-induced myocarditis and patient outcomes after drug rechallenge following myocarditis: A systematic case review.
Richardson N; Greenway SC; Bousman CA
Psychiatry Res; 2021 Nov; 305():114247. PubMed ID: 34715441
[TBL] [Abstract][Full Text] [Related]
16. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
Myles N; Myles H; Clark SR; Bird R; Siskind D
Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
[TBL] [Abstract][Full Text] [Related]
17. Lithium and clozapine rechallenge: a retrospective case analysis.
Kanaan RA; Kerwin RW
J Clin Psychiatry; 2006 May; 67(5):756-60. PubMed ID: 16841625
[TBL] [Abstract][Full Text] [Related]
18. Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?
Nielsen J; Correll CU; Manu P; Kane JM
J Clin Psychiatry; 2013 Jun; 74(6):603-13; quiz 613. PubMed ID: 23842012
[TBL] [Abstract][Full Text] [Related]
19. Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.
Hollingworth SA; Winckel K; Saiepour N; Wheeler AJ; Myles N; Siskind D
Psychopharmacology (Berl); 2018 Jul; 235(7):1915-1921. PubMed ID: 29589067
[TBL] [Abstract][Full Text] [Related]
20. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.
Illing M; Ancill R
Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793
[No Abstract] [Full Text] [Related]
[Next] [New Search]
